This Week in Cardiology

 
 

  • Sep 30 2022 This Week in Cardiology   Pulmonary embolism, coffee, when DOACs don’t work, lipoprotein (a), and the marginal benefits of current CV therapy are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Sep 23 2022 This Week in Cardiology   The PROTECTED TAVR trial of an embolic protection device, renal denervation for hypertension, percutaneouls left atrial appendage closure, and deprescribing aspirin are discussed in this weeks podcast.
  • Sep 16 This Week in Cardiology   The safety of very low LDL-C, the win-ratio analytic method, sacubitril/valsartan, SGLT2 inhibitors, and percutaneous left atrial appendage closure are discussed in this week’s podcast.
  • Sep 9 2022 This Week in Cardiology   A potential new anticoagulant, surveillance stress testing, a trial misinterpretation, an old diuretic, and AI in cardiology are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Sep 2 2022 This Week in Cardiology   A second ESC review covering REVIVED, the DANCAVAS CV screening trial, DELIVER on dapagliflozin in HF with mildly reduced EF, and the INVICTUS trial of rivaroxaban in rheumatic heart disease.
  • Aug 26 2022 This Week in Cardiology   Early rhythm control in AF, treating coronary artery disease before transcatheter aortic valve implantation, and an ESC 2022 preview are the topics John Mandrola, MD, covers in this week’s podcast.
  • Aug 19 2022 This Week in Cardiology   The obesity paradox in AF and paradoxes in general, digital health gets whacked again, and direct-to-consumer ads are the topics discussed by John Mandrola, MD in this week’s podcast.
  • Aug 12 2022 This Week in Cardiology   AF screening; sodium, potassium, BP, and CV outcomes; drug prices; and cardio-respiratory fitness are the topics John Mandrola, MD, covers in this week’s podcast.
  • Aug 5 2022 This Week in Cardiology   Hyperkalemia in heart failure, CV health in America, primary prevention ICDs, and a debate about posters at medical meetings are the topics discussed by John Mandrola, MD in this week’s podcast.
  • Jul 29 2022 This Week in Cardiology   A big new HF and EP trial, doctors and probability, LV assist devices in cardiogenic shock, vitamin D, and exercise in PAD are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Jul 22 2022 This Week in Cardiology   Therapeutic fashion and conduction system pacing, early rhythm control in AF, statins in CKD, and salt intake in HF are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Jul 15 2022 This Week In Cardiology   The LIFE study, multimorbidity and evidence translation, cardiac arrest and therapeutic fashion, diabetes and cardiology, and EP cuts are the topics John Mandrola, MD, tackles in this week’s podcast.
  • Jul 8 2022 This Week in Cardiology   Questions about Vascepa (IPE) benefits in REDUCE-IT, US heart health, pharmacist prescribing, and who should get statins are the topics discussed this week
  • Jun 24 2022 This Week in Cardiology   A non-significant but wonderful trial in AF, smoking and HF, vitamins, and pre-op risk screening are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Jun 17 2022 This Week in Cardiology   Statin Intolerance, external validity of trials, contrast shortage, and expansion of cardiology into diabetes and nephrology are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Jun 10 2022 This Week in Cardiology   More ISCHEMIA controversy, health Insurance and CV outcomes, testosterone, and flawed observational studies are the topics discussed by John Mandrola, MD in this week’s podcast.
  • Jun 3 2022 This Week in Cardiology   Devices for HF, Twitter for disseminating science, HDL levels, and dubious post-hoc studies are the topics John Mandrola, MD, discusses in this week’s podcast.
  • May 20 2022 This Week in Cardiology   Ischemia vs anatomic testing for CAD, UK-TAVI trial, TAVI for AR? and post-PCI anti-thrombotics are the topics John Mandrola, MD, discusses in this week’s podcast.
  • May 13 2022 This Week in Cardiology   Obstructive hypertrophic cardiomyopathy and mavacamten, SGLT2 inhibitors, the triple whammy, espresso, and clinician burnout are the topics John Mandrola, MD, covers in today’s podcast.
  • May 6 2022 This Week in Cardiology   HRS meeting presentations: conduction system pacing, AF in the ED, a possible new treatment for vagal bradycardia, and women in EP are the topics John Mandrola, MD, discusses in this week’s podcast.